TLDR Fumaric acid esters might help treat alopecia areata, but more research is needed.
The retrospective analysis examined the use of fumaric acid esters in 13 patients with alopecia areata (AA), an autoimmune disease causing non-scarring hair loss. The study aimed to evaluate the effectiveness of this treatment, given the limited success of existing local and systemic therapies. The findings suggested that fumaric acid esters might offer a potential treatment option for AA, although the small sample size of 13 patients indicated that further research with larger cohorts would be necessary to confirm these results.
Cited in this study
4 / 4 results
56 citations
,
April 2017 in “Journal of dermatological science” New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.
238 citations
,
January 2017 in “Journal of The American Academy of Dermatology” Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.
14 citations
,
January 2016 in “Annals of dermatology/Annals of Dermatology” Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.
44 citations
,
September 2014 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.
April 2019 in “International journal of research in dermatology” A child with rough nails also had hair loss and allergies.
